Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 14,024

Document Document Title
WO/2013/177224
The invention provides novel compounds having the general formula (I) and pharmaceutically acceptable salts thereof, wherein the variables RA, subscript n, ring A, X2, L, subscript m, X1, B, R1, R2, R3, R4, R5 and RN have the meaning as ...  
WO/2013/174925
PATENT APPLICATION. TITLE: NEW STRIGOLACTONE ANALOGUES AND THE USE THEREOF FOR THE TREATMENT OF PLANTS. ABSTRACT: The invention concerns a compound with the general formula (I): (I) in which X represents O, S, NH or an N-alkyl radical, R...  
WO/2013/175211
The present invention relates to the prophylaxis of acute noise- induced hearing loss by administering a compound of formula (I): wherein: W is group (Wa), group (Wb) or group (Wc):  
WO/2013/177243
A process for making the compound of Formula I utilizes the starting compound, together with sulfilimine and sulfoxide process steps later on.  
WO/2013/170694
The present invention relates to a compound as represented by formula (I), pharmaceutical composition thereof as well as preparation method and uses thereof, in particular to the uses of the compound as represented by formula (I) for tre...  
WO/2013/172239
The present invention is an acid diffusion control agent consisting of at least one compound selected from among the group consisting of a compound represented by formula (1) and a compound represented by formula (2). In formula (1), R2 ...  
WO/2013/171332
The present invention relates to tertiary amines of formula (I) for use in therapy, particularly for use in treating cardiovascular disorders. The compounds have been found to regulate phospholamban phosphorylation by interfering with th...  
WO/2013/168048
Phenacene compounds of formula (I) are disclosed. All the variables in the formula are the same as defined in the description. A thin film semiconductor comprising the above compounds, and a field effect transistor device, a photovoltaic...  
WO/2013/169651
A method of making an anti-Markovnikov addition product is carried out by reacting an acid with an alkene or alkyne in a dual catalyst reaction system to the exclusion of oxygen to produce said anti-Markovnikov addition product; the dual...  
WO/2013/169651
A method of making an anti-Markovnikov addition product is carried out by reacting an acid with an alkene or alkyne in a dual catalyst reaction system to the exclusion of oxygen to produce said anti-Markovnikov addition product; the dual...  
WO/2013/166618
The present invention discloses use of prodrug of 4,9-dihydroxy-naphtho[2,3-b]furan derivative for circumventing cancer multidrug resistance. The present invention also discloses use of prodrug of 4,9-dihydroxy-naphtho[2,3-b]furan deriva...  
WO/2013/164292
The present invention relates to compounds of general formula (I), wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activ...  
WO/2013/164729
Provided herein is an improved, commercially viable and industrially advantageous process for the preparation of a prostaglandin derivatives and intermediates thereof, in high yield and purity.  
WO/2013/158251
The invention relates to fluorinated compounds and their use in the field of pathological syndromes of the cardiovascular system. Novel fluorinated benzofuran derivatives of amiodarone and pharmaceutically acceptable salts or solvates th...  
WO/2013/156398
The present invention relates to novel processes for improved preparation of homofarnesol, especially of (3E,7E)-homofarnesol and homofarnesol preparations having an elevated content of (3E,7E)-homofarnesol (also referred to as all-E-hom...  
WO/2013/157528
Provided is a medicinal agent comprising a compound represented by general formula (1), a pharmaceutically acceptable salt of the compound or a solvate of the compound or the pharmaceutically acceptable salt. A compound represented by ge...  
WO/2013/156738
Lichesterinic acid and the derivatives of same as pigmentation inhibitors. The invention relates to the cosmetic use of a compound chosen from the compounds of formula (A) and the salts of same as an agent for depigmenting the skin and/o...  
WO/2013/156200
A process for obtaining (ethyne-1,2-diyl)bis(isobenzofuran-1,3-dione) is disclosed. In the disclosed process chloro-, bromo-, or iodoisobenzofuran-1,3-dione is reacted with ethyne in a solvent in the presence of a dissolved homogenous pa...  
WO/2013/156738
Lichesterinic acid and the derivatives of same as pigmentation inhibitors. The invention relates to the cosmetic use of a compound chosen from the compounds of formula (A) and the salts of same as an agent for depigmenting the skin and/o...  
WO/2013/152963
The invention relates to a polycondensation product comprising, as monomer components, at least one aryl polyoxyalkylene ether, at least one vicinally disubstituted aromatic compound, at least one aldehyde, and optionally further aromati...  
WO/2013/144098
The present invention relates to compounds of general formula (I), wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activ...  
WO/2013/144931
The T cells specific to human collagen type II, one of the possible autoantigens, have a crucial role in the development of rheumatoid arthritis in the context of HLA-DR4. The protein-protein interactions between the T cell receptor (TCR...  
WO/2013/146943
An arctigenin derivative is created and used for anti-aging treatment, including in order to protect skin from the sun and to recover skin elasticity. A variety of fatty acid ester derivatives, alcohol ether derivatives and alkylated der...  
WO/2013/146437
[Problem] To provide a novel compound that is useful as an agent for preventing/treating cancer. [Solution] One aspect of the present invention provides a compound expressed by the chemical formula (1) or a pharmaceutically permissible s...  
WO/2013/148255
Compositions containing tetrahydrofurfuryl and/or alkyl-substituted tetrahydrofurfuryl esters of citric acid are provided. These esters of citric acid can be formed from renewable materials and can be used, for example, as plasticizers f...  
WO/2013/142999
Disclosed is a compound of formula (1), or a pharmaceutically acceptable salt thereof, where R1, R2, R3, R4, R5, R6, R7, R7', R8, R9, R10, R11, R12 and R13 are as disclosed herein. Also, disclosed is a process for the preparation of the ...  
WO/2013/148923
Provided are catalysts suitable for the production of tetrahydrofuran from 1,4- butanediol. Also provided are methods of use of these catalyst, as well as catalyst systems. The catalysts described herein contain only Lewis acidity, but n...  
WO/2013/146085
The present invention relates to: a method for producing 5-hydroxymethyl furfural (HMF), which comprises the steps a-c described below; and a method for producing 5-hydroxymethyl furfural oxide, which comprises the steps a-d described be...  
WO/2013/148620
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected w...  
WO/2013/143259
The present invention relates to a phosphodiesterase-4 inhibitor capable of avoiding a vomit reaction. The phosphodiesterase-4 inhibitor is a compound, a prodrug or a solvate represented by DTPM. The name of DTPM is 1-(4-difluoro methoxy...  
WO/2013/147568
The present invention provides an aminostyrylbenzofuran compound of Formula (I), and a pharmaceutical composition comprising same. The pharmaceutical composition of the present invention comprising the compound of Formula (I), a pharmace...  
WO/2013/144097
The present invention relates to compounds of general formula I, (I), wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its ac...  
WO/2013/141523
The present invention relates to a method for preparing 5-acetoxymethylfurfural, comprising a step of synthesizing 5-acetoxymethylfurfural by reacting 5-halomethyl furfural with alkylammonium acetate. The present invention can provide a ...  
WO/2013/140969
The present invention is a photoresist composition which contains [A] a polymer that has a structural unit (I) containing an acid-cleavable group and a compound (I) that is represented by formula (1). In formula (1), each of R1, R2, R3 a...  
WO/2013/140946
Provided is a novel root parasitic plant germination inhibitor. Also provided is a root parasitic plant control agent comprising the root parasitic plant germination inhibitor. Further provided is a method for controlling a root parasiti...  
WO/2013/140506
Provided is a method for manufacturing 4,4'-oxydiphthalic acid with favorable productivity and high-yield via 4,4'-oxydiphthalonitrile, using 4-nitrophthalonitrile as a reaction raw material; the method including a hydrolysis step for hy...  
WO/2013/142873
The invention provides a novel, general, and facile strategy for the creation of small molecules with high structural and stereochemical complexity. Aspects of the methods include ring system distortion reactions that are systematically ...  
WO/2013/140347
Sulphonamide derivatives of benzylamine of formula (I), wherein A represents phenyl unsubstituted or substituted;or 9-or 10-membered bicyclic group, linked to –(O) x - (CH 2 ) y -through one of its aromatic carbon atoms,consisting of b...  
WO/2013/138243
The present disclosure encompasses bifunctional compounds resulting from the ring-expanding mono- and bis-carbonylation of glycidyl acrylates to afford the corresponding beta lactones and succinic anhydrides. Uses of the materials and po...  
WO/2013/138153
A process is disclosed for making dehydration products from an aqueous sugars solution including pentoses, hexoses or both, for example, an aqeous high fructose corn syrup solution, or from an aqueous solution of one or more of the alcoh...  
WO/2013/136294
A complex formed of at least one molecule of 5-(1,2-dihydroxy-ethyl) -3,4-dihydroxy-5H-furan-2-one or a derivative covalently bonded with at least one hydrocarbon radical with formula (A) as follows: wherein: • - m 1 = 1, 2, 3, 4, 5 or...  
WO/2013/138600
Radioprotector compounds including 3,3'-diindolylmethane (DIM) analogs, are provided. Further provided are methods for their use in reducing or preventing radiation damage, killing a tumor cell and protecting a non-tumor cell, and treati...  
WO/2013/136030
The present invention relates to powder compositions of a complex between an acid or a corresponding anion and at least one metal or corresponding metal cation, said corresponding anion or acid being selected from the group containing 2-...  
WO/2013/135869
The invention relates to a process for the preparation of optically active 1,2-diol of formula (S,S)-(I), or alternatively of formula (R,R)-(I) by asymmetric transfer hydrogenation of a compound of formula (II), or a compound of formula ...  
WO/2013/132262
The present invention is directed to new compounds of formula (I) as well as to pharmaceutically acceptable salts thereof, to a pharmaceutical composition comprising said compounds, and to the use of said compounds in therapy, and more p...  
WO/2013/133078
A polymer characterized by containing repeating units respectively represented by formulae [1a], [1b] and [1c]. The polymer enables the production of a single-layer-coated horizontally oriented film by a simple process. [In the formulae,...  
WO/2013/133208
The present invention is a method for producing a tetrahydrofuran compound represented by general formula (2), the method comprising a reaction step for bringing a furan compound represented by general formula (1) into contact with a pal...  
WO/2013/133489
A method for producing 5-hydroxymethyl-2-furfural (HMF) from maize syrup containing fructose comprises a conversion step in which a reaction product containing the 5-hydroxymethyl-2-furfural is produced by mixing and heating the maize sy...  
WO/2013/128378
The present invention relates to phenyl alkanoic acid derivatives (the compounds of Formula (I)); and their isotopic forms, stereoisomeric and tautomeric forms and mixtures thereof in all ratios, or pharmaceutically acceptable salts, pha...  
WO/2013/128294
The invention relates to a novel process for preparation of dronedarone of formula (I) and pharmaceutically acceptable salts thereof, characterized in that a compound of formula (II) - where L is leaving group - is reacted with compound ...  

Matches 151 - 200 out of 14,024